在老年人抗高血压药物治疗期间患痴呆症的风险
Federico Rea1, Giovanni Corrao1, Giuseppe Mancia2
1National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy; Unit of Biostatistics, Epidemiology, and Public Health, Laboratory of Healthcare Research and Pharmacoepidemiology, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Journal of the American College of Cardiology
|March 27, 2024
概括
用抗高血压药物降低高血压可能会降低老年人痴呆风险. 这种益处扩展到非常老和脆弱的个体,表明血压管理对于认知健康的更广泛适用性.
科学领域:
- 老年学和老年医学是老年学和老年医学.
- 神经学和认知科学 神经学和认知科学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 确定的证据将降低高血压与降低痴呆风险联系在一起.
- 这种保护作用对老年人群的普遍性仍在研究中.
研究的目的:
- 评估抗高血压药物治疗对痴呆风险的影响.
- 为了在65岁及以上的新型抗高血压药物使用者的多样群体中评估这种效应.
主要方法:
- 在意大利伦巴第省 (Lombardy,意大利) 进行了215547名患者 (≥65岁) 的嵌套病例控制研究 (2009-2012).
- 13,812个痴呆症/阿尔茨海默病病例与5个对照组相匹配.
- 暴露量以抗高血压药物所覆盖的随访比例来衡量;使用条件逻辑回归.
主要成果:
- 抗高血压治疗显示与痴呆风险有相反的关联.
- 较高的暴露水平与更大的风险降低相关:12% (中等) 和24% (高).
- 在非常老 (≥85岁) 和脆弱的患者小组中观察到显著的风险降低.
结论:
- 抗高血压药物治疗与老年一般人口中痴呆症风险降低有关.
- 这种保护性关联对非常老和脆弱的个人来说都是真实的.
相关概念视频
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Antihypertensive Drugs: Action of Diuretics
680
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
680
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61


